Jump to ContentJump to Main Navigation
Show Summary Details

Journal of Medical Biochemistry

The Journal of Society of Medical Biochemists of Serbia


IMPACT FACTOR 2015: 0.742

SCImago Journal Rank (SJR) 2015: 0.204
Source Normalized Impact per Paper (SNIP) 2015: 0.333
Impact per Publication (IPP) 2015: 0.507

Open Access
Online
ISSN
1452-8266
See all formats and pricing

 


Select Volume and Issue

Issues

Role of Retinol-Binding Protein 4 in Obese Asian Indians with Metabolic Syndrome

Nirupama Shivakumar1 / Meghanaa Kumar1 / Manasa Aswathanarayan1 / Maanasa Venkatesh1 / Manasa Sheshadri1 / Shreehari Deshmukh1 / Pranav Srinivasan1 / Mala Dharmalingam1 / Sara Marcus1

M.S. Ramaiah Medical College, Bangalore, India1

Department of Endocrinology, M.S. Ramaiah Medical College, Bangalore, India2

Department of Biochemistry, MSU-GEF International Medical School, Bangalore, India3

This content is open access.

Citation Information: Journal of Medical Biochemistry. Volume 31, Issue 1, Pages 40–46, ISSN (Online) 1452-8266, ISSN (Print) 1452-8258, DOI: 10.2478/v10011-011-0032-4, August 2011

Publication History

Published Online:
2011-08-25

Role of Retinol-Binding Protein 4 in Obese Asian Indians with Metabolic Syndrome

Retinol-binding protein 4 is an adipocytokine separately implicated in the development of obesity-related insulin resistance and proatherogenic lipid profile, however, its role in humans is unclear. This study was carried out to assess the role of retinol-binding protein 4 as a potential marker of metabolic syndrome in obese Asian Indians (a high-risk population for diabetes). 52 obese (BMI >23 kg/m2) Asian Indians were grouped into those with and without metabolic syndrome based on IDF criteria and compared with healthy controls. The anthropometric and biochemical parameters (fasting blood sugar, lipid profile, serum insulin, high-sensitivity C-reactive protein, and retinol-binding protein 4) were estimated. The obese groups had significantly altered adiposity indices, insulin resistance parameters (fasting blood sugar (only in the metabolic syndrome group), serum insulin, HOMA-IR and QUICKI), index of inflammation (C-reactive protein) and proatherogenic dyslipidemic profile (serum triglycerides, VLDL-cholesterol, and triglyceride/HDL-cholesterol ratio). Retinol-binding protein 4 levels were elevated in the obese groups, but were not significant. Retinol-binding protein 4 levels were correlated with anthro-pometric parameters and atherogenic lipids, while C-reactive protein was correlated with anthropometric and insulin resistance parameters in the entire group of subjects. Although these correlations were not observed in the obese groups, in the control group, retinol-binding protein 4 was correlated to the lipid parameters and C-reactive protein to adiposity indices. Thus, the role of retinol-binding protein 4 as a potential marker of metabolic syndrome is limited to the prediction of proatherogenic risk among Asian Indians.

Uloga Retinol-Vezujućeg Proteina 4 Kod Gojaznih Indijaca sa Metabolićkim Sindromom

Retinol-vezujući protein 4 je adipocitokin koji ima zasebnu ulogu u razvoju insulinske rezistencije u gojaznosti i proaterogenog lipidskog profila, međutim, ona kod ljudi nije razjašnjena. Ova studija izvedena je kako bi se utvrdila uloga retinol-vezujućeg proteina 4 kao potencijalnog markera metaboličkog sindroma kod gojaznih Indijaca (populacije sa visokim rizikom za šećernu bolest). Pedeset dvoje gojaznih ispitanika (indeks telesne mase > 23 kg/m2) podeljeni su na one sa i bez metaboličkog sindroma na osnovu kriterijuma IDF i upoređeni sa zdravim kontrolnim subjektima. Određeni su antropometrijski i biohemijski parametri (šećer u krvi, lipidski profil, insulin u serumu, visokoosetljivi C-reaktivni protein i retinol-vezujući protein 4). U gojaznim grupama značajno su bili izmenjeni adipozni indeksi, parametri insulinske rezistencije (šećer u krvi (samo u grupi sa metaboličkim sindromom), insulin u serumu, HOMA-IR i QUICKI), indeks inflamacije (C-reaktivni protein) i proaterogeni dislipidemijski profil (trigliceridi, VLDL-holesterol i odnos trigliceridi/HDL-holesterol u serumu). Nivoi retinol-vezujućeg proteina 4 bili su u korelaciji sa antropometrijskim parametrima i aterogenim lipidima, dok je C-reaktivni protein korelisao sa antropometrijskim kao i parametrima insulinske rezistencije kod svih ispitanika obuhvaćenih studijom. Iako ove korelacije nisu uočene u gojaznim grupama, retinol-vezujući protein 4 bio je u korelaciji sa lipidskim parametrima a C-reaktivni protein sa adipoznim indeksima. Stoga je uloga retinol-vezujućeg proteina 4 kao potencijalnog markera metaboličkog sindroma ograničena na predviđanje proaterogenog rizika kod Indijaca.

Keywords: retinol-binding protein 4; obesity; metabolic syndrome; Asian Indians; insulin resistance

Keywords: retinol-vezujući protein 4; gojaznost; metabolički sindrom; Indijci; insulinska rezistencija

  • Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord 2009; 7: 497-514. [Web of Science] [PubMed]

  • Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007; 23: 127-34. [Web of Science] [PubMed]

  • Dharmalingam M, Dev N, Marcus SR. High-sensitivity C-reactive protein levels in obese women [abstract]. Diab Res Clin Pract 2008; 79: Suppl 1: S98-S99. [Crossref]

  • Veigas NM, Dharmalingam M, Marcus SR. Oxidative stress in obesity and metabolic syndrome in Asian Indians. J Med Biochem 2011; 30: 115-20. [Web of Science]

  • von Eynatten M, Humpert PM. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev Mol Diagn 2008; 8: 289-99. [Web of Science]

  • de Ferranti S, Mozaffarian D. The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 945-55. [Web of Science]

  • Jensen MD. Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93: s57-s63. [Crossref]

  • Shea J, Randell E, Vasdev S, Wang PP, Roebothan B, Sun G. Serum retinol-binding protein 4 concentrations in response to short-term overfeeding in normalweight, overweight, and obese men. Am J Clin Nutr 2007; 86: 1310-15.

  • Mallat Z, Simon T, Benessiano J, Clement K, Taleb S, Wareham NJ, et al. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. J Clin Endocrinol Metab 2009; 94: 255-60. [Web of Science] [PubMed]

  • Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005; 436: 356-62. [PubMed]

  • Kloting N, Graham TE, Berndt J, Kralisch S, Kovacs P, Wason CJ, et al. Serum retinol binding protein (RBP4) is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker for intra-abdominal fat mass. Cell Metab 2007; 6: 79-87. [Web of Science] [PubMed]

  • von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, Nawroth PP, et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007; 50: 1930-37.

  • Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee M-J, et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007; 92: 2590-97. [Web of Science]

  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52. [PubMed]

  • Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome - a new worldwide definition. Lancet 2005; 366:1059-62.

  • WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63. [PubMed]

  • Parikh RM, Joshi SR, Menon PS, Shah NS. Index of central obesity - a novel parameter. Med Hypotheses 2007; 68: 1272-75. [Web of Science] [PubMed]

  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19. [PubMed]

  • Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-10. [PubMed]

  • Despres J-P, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008; 28: 1039-49. [Web of Science] [PubMed]

  • Poirier P. Adiposity and cardiovascular disease: are we using the right definition of obesity? Eur Heart J 2007; 28: 2047-8. [PubMed] [Web of Science]

  • Chandalia M, Abate N. Metabolic complications of obesity: inflated or inflamed? J Diabetes Complications 2007; 21: 128-36. [Web of Science] [PubMed]

  • Bajzova M, Kovacikova M, Vitkova M, Klimcakova E, Polak J, Kovacova Z, et al. Retinol-binding protein 4 expression in visceral and subcutaneous fat in human obesity. Physiol Res 2008; 57: 927-34. [PubMed]

  • Shim CY, Sungha P, Kim J-S, Shin DJ, Ko Y-G, Kang S-M, et al. Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin, with insulin resistance in non-diabetic hypertensive patients. Yonsei Med J 2010; 51: 375-84. [Web of Science] [PubMed]

  • Broch M, Gomez JM, Auguet MT, Vilarrasa N, Pastor R, Elio I, et. al. Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women. Obes Surg 2010; 20: 1258-64. [Crossref]

  • Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 2007; 92: 1971-4. [PubMed] [Web of Science]

  • Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 2007; 92: 2712-19.

  • Ingenbleek Y, Young VR. Significance of transthyretin in protein metabolism. Clin Chem Lab Med 2002; 40: 1281-91. [PubMed]

  • Baeten JM, Richardson BA, Bankson DD, Wener MH, Kreiss JK, Lavreys L, et al. Use of serum retinol-binding protein for prediction of vitamin A deficiency: effects of HIV-1 infection, protein malnutrition, and the acute phase response. Am J Clin Nutr 2004; 79: 218-25. [PubMed]

  • McLaughlin T, Abbasi F, Lamendola C, Liang L, Reaven G, Schaaf P, Reaven P. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002; 106: 2908-12.

  • Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006; 354: 2552-63. [PubMed]

  • Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007; 92: 4827-34. [PubMed]

  • Kovacs P, Geyer M, Berndt J, Kloting N, Graham TE, Bottcher Y, et al. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes 2007; 56: 3095-100. [PubMed]

  • Munkhtulga L, Nakayama K, Utsumi N, Yanagisawa Y, Gotoh T, Omi T, et al. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum Genet 2007; 120: 879-88. [PubMed]

  • Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. Retinol-binding protein 4 in twins. Regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 2009; 58: 54-60. [Crossref] [Web of Science]

  • Stankov K. Genetic predisposition for type 1 Diabetes Mellitus - The role of endoplasmic reticulum stress in human disease etiopathogenesis. Journal of Medical Biochemistry 2010; 29: 139-49. [Web of Science]

  • Weiss R, Otvos JD, Sinnreich R, Miserez AR, Kark JD. The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr 2011; 158: 44-50. [PubMed] [Web of Science]

Comments (0)

Please log in or register to comment.